| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,175 |
2,845 |
$220K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,181 |
1,002 |
$37K |
| 99215 |
Prolong outpt/office vis |
182 |
160 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
77 |
75 |
$5K |
| 99401 |
|
131 |
127 |
$4K |
| 99490 |
Ccm add 20min |
950 |
902 |
$4K |
| 99307 |
|
66 |
60 |
$2K |
| 82947 |
|
405 |
373 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
13 |
$615.72 |
| 36415 |
Collection of venous blood by venipuncture |
260 |
251 |
$558.92 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
40 |
38 |
$545.41 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
37 |
36 |
$492.60 |
| 90756 |
|
27 |
26 |
$345.97 |
| 99318 |
|
15 |
15 |
$334.17 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
15 |
15 |
$213.78 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
13 |
13 |
$188.88 |
| 81000 |
|
15 |
15 |
$43.21 |
| 1159F |
|
31 |
27 |
$0.00 |
| 1160F |
|
31 |
27 |
$0.00 |
| 3008F |
|
30 |
25 |
$0.00 |